Skip to main content
. 2002 Dec;54(6):657–664. doi: 10.1046/j.1365-2125.2002.01707.x

Table 4.

Summary of GP (n = 46) and Community Pharmacist (n = 35) feedback in the questionnaires about the MIDS (number and percentage in parenthesis)

General practitioners Community pharmacists
Useful for
Transfer of information 41 (89.1%) 32 (91.4%)
GP 45 (97.8%) 33 (94.3%)
Community pharmacist 31 (67.4%) 34 (97.1%)
Nurse 41 (89.1%) 32 (91.4%)
Social worker 11 (23.9%) 14 (40.0%)
Not useful at all 4 (8.7%) 0 (0%)
Information required
Name of drug 46 (100%) 35 (100%)
When to take each drug 35 (76.1%) 33 (94.3%)
Why each drug prescribed 18 (39.1%) 24 (68.6%)
How long to prescribe 44 (95.7%) 34 (97.1%)
Side-effects 15 (32.6%) 6 (17.1%)
Correct storage of item 14 (30.4%) 25 (71.4%)
Reason for admission 45 (97.8%) 19 (54.3%)
Main diagnosis 46 (100%) 31 (88.6%)
Other clinical problems 45 (97.8%) 30 (85.7%)
Follow-up information 44 (95.7%) 29 (82.9%)
Potential problems with MIDS
Patients may lose their MIDS 44 (95.7%) 35 (100%)
Confidentiality 25 (54.3%) 14 (40%)
Diagnosis given to patient 28 (60.9%) 10 (28.6%)
Diagnosis given to pharmacist 30 (65.2%) 2 (5.7%)
Diagnosis given to other healthcare 14 (30.4%) 1 (2.9%)
Not all patients use same pharmacy 42 (91.3%) 23 (65.7%)
Legibility of hand-written form 46 (100%) 34 (97.1%)